drugset / Trial / NCT06906809

Effect of Phenytoin or Itraconazole on How BGB-16673 is Absorbed and Removed From the Body in Healthy Participants

NCT06906809

Phase 1 Completed 37 enrolled BeiGene
Non-randomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to investigate the effect of coadministration of phenytoin or itraconazole on the pharmacokinetics of BGB-16673 in healthy participants.

Timeline

Start
2025-04-03
Primary completion
2025-10-13
Completion
2025-10-13

Drugs

EvaluationDrugModalityDoseRoute
Subject BGB-16673 Other / unclassified Oral
Subject Itraconazole Small molecule Oral
Subject Phenytoin Unknown Oral

Indications

No indication recorded.